Technical Analysis for SPRY - ARS Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
B 8.26 -2.82% -0.24
SPRY closed down 2.82 percent on Wednesday, April 24, 2024, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 13
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Resistance Bearish -2.82%
Stochastic Buy Signal Bullish -2.82%
Lower Bollinger Band Walk Weakness -2.82%
Gapped Up Strength -2.82%
Oversold Stochastic Weakness -2.82%
MACD Bearish Centerline Cross Bearish 0.61%
Lower Bollinger Band Walk Weakness 0.61%
Below Lower BB Weakness 0.61%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 16 hours ago
Lower Bollinger Band Support about 17 hours ago
Down 3% about 19 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
Fell Below Previous Day's Low about 19 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Allergy Respiratory Therapy Respiratory Diseases Type I Hypersensitivity Allergology Nasal Administration Anaphylaxis

Is SPRY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.27
52 Week Low 2.55
Average Volume 783,273
200-Day Moving Average 6.38
50-Day Moving Average 8.76
20-Day Moving Average 9.19
10-Day Moving Average 8.76
Average True Range 0.51
RSI (14) 40.48
ADX 23.62
+DI 20.07
-DI 24.26
Chandelier Exit (Long, 3 ATRs) 9.75
Chandelier Exit (Short, 3 ATRs) 9.66
Upper Bollinger Bands 10.32
Lower Bollinger Band 8.07
Percent B (%b) 0.09
BandWidth 24.55
MACD Line -0.12
MACD Signal Line 0.06
MACD Histogram -0.1768
Fundamentals Value
Market Cap 792.94 Million
Num Shares 96 Million
EPS -0.64
Price-to-Earnings (P/E) Ratio -12.91
Price-to-Sales 22655.34
Price-to-Book 2.63
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.85
Resistance 3 (R3) 8.88 8.71 8.75
Resistance 2 (R2) 8.71 8.56 8.70 8.71
Resistance 1 (R1) 8.49 8.47 8.40 8.46 8.68
Pivot Point 8.32 8.32 8.28 8.31 8.32
Support 1 (S1) 8.10 8.17 8.01 8.07 7.84
Support 2 (S2) 7.93 8.08 7.92 7.81
Support 3 (S3) 7.71 7.93 7.77
Support 4 (S4) 7.68